 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
2/14/20 Revance Therapeutics, Inc. 8-K:1,2,3,8 2/11/20 14:1.4M Donnelley … Solutions/FA
2/14/20 ArrowMark Colorado Holdings LLC SC 13G/A 1:52K Revance Therapeutics, Inc. Adviser Compliance … LLC
| ____________ | | ¹ | Filing/Form Types: -K | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. |
|
